Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominantly affects women of childbearing age. Pregnancy in SLE patients poses unique challenges due to the potential impact on maternal and fetal outcomes. We provide an overview of the management of SLE during pregnancy, including preconception risk stratification and counseling, treatment, and disease activity monitoring. These assessments are critical to minimize maternal and fetal adverse events in pregnant patients with SLE. Disease flares, preeclampsia, antiphospholipid syndrome complications, and maternal mortality are the major risks for a woman with SLE during gestation. Timely treatment of SLE relapse, differentiation of preeclampsia from lupus nephritis, and tailored management for antiphospholipid syndrome are essential for a successful pregnancy. Fetal outcomes include neonatal lupus (NL), preterm birth, cesarean delivery, fetal growth restriction (FGR), and small-for-gestational-age (SGA) infants. We focused on NL, linked to maternal anti-Ro/SS-A and anti-La/SS-B antibodies, which can lead to various manifestations, particularly cardiac abnormalities, in newborns. While there is a common consensus regarding the preventive effect of hydroxychloroquine, the role of echocardiographic monitoring and fluorinated steroid treatment is still debated. Finally, close postpartum monitoring and counseling for subsequent pregnancies are crucial aspects of care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pregnant patients with autoimmune conditions are at greater risk for developing adverse pregnancy outcomes.133,134”
From Guidelines for antenatal and preoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 1)—2025 update (2026) · cites this paper as [134]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,318 · cited 1×
“According to the 2019 EULAR recommendations [59], pregnant patients with SLE and a high-risk aPL profile, without previous thrombotic or pregnancy episodes, should be treated with LDA (75–100 mg/day) during pregnancy.”
MethodCombined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Petri, M., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M., Merrill, J. T., Belmont, H. M., Askanase, A. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051135 · Cited by 1,166
Perinatal mental illness: Definition, description and aetiology
O'Hara, M. W., & Wisner, K. L. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.09.002 · Cited by 986 · cited 1×
“Additionally, it is important to remember that the prevalence of postpartum depression in Europe is estimated to be around 10% [91].”
BackgroundAndreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer-Betz, R., Forger, F., Moraes-Fontes, M. F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 945 · cited 8×
“Indeed, it can contribute in maintaining disease control, and its discontinuation has been linked to an increased risk of flares during pregnancy [7].”
BackgroundMethodResultInfluentialSelf-citationPre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis
Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2013) · BMJ · doi:10.1136/bmj.f6564 · Cited by 940 · cited 1×
“Between 20% and 30% of SLE pregnancies are at risk of developing PE [38,44,45].”
BackgroundSammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41191 · Cited by 790 · cited 4×
“Several studies [2] showed that the number of pregnancies in patients with systemic lupus erythematosus (SLE) is lower than in the general population.”
BackgroundInfluentialRoberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679 · cited 1×
“A meta-analysis involving over 20,000 pregnant women revealed that when LDA was given before 16 weeks, there were significant dose-dependent reductions in the rates of FGR [90].”
MethodSmyth, A., Oliveira, G. H. M., Lahr, B. D., Bailey, K. R., Norby, S. M., & Garovic, V. D. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240110 · Cited by 660 · cited 2×
“The risk increased in cases of active disease or renal flares [40,88,89].”
BackgroundA national study of the complications of lupus in pregnancy
Clowse, M. E. B., Jamison, M., Myers, E., & James, A. H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.03.012 · Cited by 609 · cited 1×
“In a US national study of 13,555 SLE pregnancies from 2000 to 2003, Clowse et al. [60] found that the risk of maternal death (325/100,000 live births) was more than 20-fold higher than in the non-SLE population.”
BackgroundPredictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study
Buyon, J. P., Kim, M. Y., Guerra, M. M., Laskin, C. A., Petri, M., Lockshin, M. D., Sammaritano, L., Branch, D. W., Porter, T. F., Sawitzke, A., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2235 · Cited by 567 · cited 2×
“Notably, most disease flares during pregnancy affect the same organs involved before pregnancy [11,12].”
Background
Research works printed but not linked: 1
- Amoura, 2005, Pleading to maintain hydroxychloroquine throughout Lupus pregnancies, Rev. Med. Interne, 26, 467
Cited by
Wilson, R. D., Monks, D. T., Sharawi, N., Bamber, J., Panelli, D. M., Sauro, K. M., Shah, P. S., Muraca, G. M., Metcalfe, A., Wood, S. L., et al. (2026) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.01.014 · Cited by 22
Single-cell profiling of the peripheral blood immune landscape during mid- and late-stage pregnancy
Gao, F., Li, X., Wang, H., Xu, Z. C., Qian, W., & Bai, G. (2024) · Physiological Genomics · doi:10.1152/physiolgenomics.00041.2024 · Cited by 5
Du, M., Zhang, R., Na, Y., Peng, L., & Bao, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1756063 · Cited by 2
Yerlanova, D., Mukhamediyarov, M., Zimba, O., Korkosz, M., & Koçyiğit, B. F. (2026) · Rheumatology International · doi:10.1007/s00296-026-06086-4 · Cited by 2
Immunologie de la grossesse et du post-partum
Lazaro, E., & Truchetet, M. (2025) · Revue du Rhumatisme · doi:10.1016/j.rhum.2025.09.001 · Cited by 1
Metadata
- Authors
- Gamba, A., Zen, M., Depascale, R., Calligaro, A., Gatto, M., Iaccarino, L., & Doria, A.
- Affiliations
- University of Padua (IT)
- University of Turin (IT)
- Corresponding author
- Doria, Andrea
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2024-06-13
- Volume
- 13
- Issue
- 12
- Pages
- 3454
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC11204490
- OpenAlex
- W4399633294
- Cited by
- 25
- References
- 94
- Citations by year
- 2026: 14 · 2025: 9 · 2024: 2
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Issues in Pregnancy
- Keywords
- systemic lupus erythematosus, pregnancy, preconception counseling, risk stratification, disease activity monitoring, preeclampsia, lupus nephritis, antiphospholipid syndrome, neonatal lupus erythematosus, anti-SSA antibodies, anti-SSB antibodies, fetal growth restriction, small for gestational age, preterm birth, cesarean section, hydroxychloroquine, postpartum monitoring, maternal mortality, fetal outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support. https://app.cochat.ai/papers/10.3390/jcm13123454
- The paper
- Gamba, A., Zen, M., Depascale, R., Calligaro, A., Gatto, M., Iaccarino, L., & Doria, A. (2024). Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13123454
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
